PPT-Chronic pain opioid sparing trials: Research designs, methods, and study execution

Research designs methods and study execution Michael C Rowbotham MD Chief Research Officer Sutter Health Adjunct Professor UCSF Anesthesia Professor Emeritus UCSF Neurology What does opioid sparing mean and what are the. Eva Szigethy MD, PhD . Associate Professor of Psychiatry, Pediatrics and Medicine. Director, Visceral Inflammation and Pain (VIP) Center. Division of Gastroenterology. szigethye@upmc.edu. Szigethy: Disclosures. Annie Ottney, . PharmD. , BCPS. Learning Objective. Identify non-opioid medications that can be used in the management of chronic pain. Opioid Epidemic . Concurrent use of opioids and benzodiazepines across United States is HIGH. MPhA. MTM Fall Symposium. Kathryn Perrotta, . PharmD. , MBA, BCPS. November 16, 2012. Disclosure Statement. Define the health economic impact of the use of . opioid. analgesics in the treatment of pain . The Role of Opioid Medication in Chronic Pain Management Lorraine Widdall, MS APRN BC Interventional Spine and Pain Center Effective December 15, 2013 Emergency rule that temporarily adds provisions under P.L. 185-2013 (SEA246) regarding physicians prescribing opioids for chronic pain. Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine 1 What is the Evidence for an Opioid-Sparing Effect of Cannabis? Assistant Professor Patrick H. Finan, Ph.D Appropriate Opioid Medication Use as Part of a Comprehensive Pain Management Approach MPhA MTM Fall Symposium Kathryn Perrotta, PharmD , MBA, BCPS November 16, 2012 Disclosure Statement Define the health economic impact of the use of Attacking Pain on all Fronts Edward C. Covington, M.D. Why a Symposium on Pain? It’s difficult Many treatments, none fully effective Patients suffer unnecessarily Optimal treatment requires A combination of interventions Dean Drosnes, MD, FASAM. Associate Medical Director. Director, Chronic Pain Treatment Program. Caron Treatment Centers. Disclosures. Name. Commercial Interests. Relevant Financial Relationships: What Was Received. Daniel P. Edney MD FACP. Objectives. Review common complications. Review CDC treatment guidelines. Review basic exit strategies. Common Complications. Tolerance. Dependency. Opioid Induced Hyperalgesia. Richard W. Rosenquist, M.D.. Chairman, Pain Management Department. Cleveland Clinic. Cleveland, OH. Disclosure. Royalties: . UpToDate. Royalties: Oxford Medical Press. Consultant: Mainstay Medical. Nathaniel Katz, MD, MS. Associate Professor of Anesthesia, Tufts University. CEO, Analgesic Solutions. . IMMPACT-XXI . July 26-27, 2018 Washington, DC. Scenarios Hypotheses. Non-opioid analgesic. Feedback from the Oxford Advanced Pain and Symptom Management Course –July 18. Anne Hounsell, Speciality Doctor, The Rowans Hospice. 6/12/18. Objectives. The use of opioids in CNCP-risks and benefits.. . Pain. An . Educational . Slide. . Set. American Society of Hematology . 2020 Guidelines . for . Management of . Venous . Thromboembolism. Slide . set. . authors:. Ahmar . U. . Zaidi, . MD, . Children’s . Lets review the drug cupboard. Paracetamol . Does it work?. Not sure . how. paracetamol works? . . - COX-2, ‘cannabinoid’, serotonin? . Mainstay analgesic in most chronic pain protocols. Not .